EHA 2022 | BPDCN: unmet needs and challenges
Uwe Platzbecker
• 21 Jun 2022
Uwe Platzbecker, MD, University of Leipzig, Leipzig, Germany, shares some insights into unmet needs in blastic plasmacytoid dendritic cell neoplasm (BPDCN), drawing focus on the importance of maintaining remission with novel treatment approaches. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Disclosures
Receiving grant support, paid to GWT-TUD, from Amgen, lecture fees, grant support, paid to the University of Leipzig, fees for serving on a steering committee, consulting fees, and travel support from Celgene, grant support, paid to GWT-TUD, from Janssen Biotech, grant support, paid to University Dresden, from Merck and Novartis, and lecture fees from Novartis.
